CAR-T: trailblazing the path from clinical development to the clinic

被引：0
|
作者：
Samuele Butera
机构：
[1] One Health Plaza,Novartis Oncology
来源：
Gene Therapy | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 164
页数：1
相关论文
共 50 条
  • [41] Challenges of driving CD30-directed CAR-T cells to the clinic
    Natalie S. Grover
    Barbara Savoldo
    BMC Cancer, 19
  • [42] Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020)
    Ivica, Nikola A.
    Young, Colin M.
    HEALTHCARE, 2021, 9 (08)
  • [43] Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?
    Drougkas, Konstantinos
    Karampinos, Konstantinos
    Karavolias, Ioannis
    Koumprentziotis, Ioannis-Alexios
    Ploumaki, Ioanna
    Triantafyllou, Efthymios
    Trontzas, Ioannis
    Kotteas, Elias
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2709 - 2734
  • [44] Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?
    Konstantinos Drougkas
    Konstantinos Karampinos
    Ioannis Karavolias
    Ioannis-Alexios Koumprentziotis
    Ioanna Ploumaki
    Efthymios Triantafyllou
    Ioannis Trontzas
    Elias Kotteas
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2709 - 2734
  • [45] Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
    Maria Caterina Cavallo
    Marianna Cavazza
    Francesca Bonifazi
    Beatrice Casadei
    Ilaria Cutini
    Barbara Tonietti
    Riccardo Saccardi
    PierLuigi Zinzani
    Claudio Jommi
    BMC Health Services Research, 24
  • [46] Introducing CAR-T therapy in Switzerland - a clinical and diagnostic perspective
    Pabst, Thomas
    Joncourt, Raphael
    Gfeller, Eva
    Fux, Michaela
    Wiedemann, Gertrud
    Porret, Naomi
    Amstutz, Ursula
    Jeker, Barbara
    Baerlocher, Gabriela
    Daskalakis, Michael
    Zeerleder, Sacha
    Bacher, Ulrike
    Novak, Urban
    SWISS MEDICAL WEEKLY, 2019, 149 : 6S - 6S
  • [47] Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment
    Watanabe, Norihiro
    McKenna, Mary Kathryn
    Shaw, Amanda Rosewell
    Suzuki, Masataka
    MOLECULAR THERAPY, 2021, 29 (02) : 505 - 520
  • [48] Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
    Chen, Kun
    Wang, Shuhang
    Qi, Dan
    Ma, Peiwen
    Fang, Yuan
    Jiang, Ning
    Wu, Erxi
    Li, Ning
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Deconvolution of clinical variance in CAR-T cell pharmacology and response
    Daniel C. Kirouac
    Cole Zmurchok
    Avisek Deyati
    Jordan Sicherman
    Chris Bond
    Peter W. Zandstra
    Nature Biotechnology, 2023, 41 : 1606 - 1617
  • [50] Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
    Cavallo, Maria Caterina
    Cavazza, Marianna
    Bonifazi, Francesca
    Casadei, Beatrice
    Cutini, Ilaria
    Tonietti, Barbara
    Saccardi, Riccardo
    Zinzani, Pierluigi
    Jommi, Claudio
    BMC HEALTH SERVICES RESEARCH, 2024, 24 (01)
12345